CDC Advisers Vote to Recommend Pfizer’s Covid-19 Vaccine
- Doctors urged to closely monitor those with allergic reactions
- Pregnant women can opt to get vaccine, committee recommends
An example of the Pfizer Covid-19 vaccine vial at a Senate Commerce Committee hearing.
Photographer: Andrew Harnik/AP/Bloomberg
This article is for subscribers only.
A panel of advisers to the Centers for Disease Control and Prevention voted to recommend that people age 16 and older receive Pfizer Inc. and BioNTech SE’s Covid-19 vaccine, clearing away one of the final hurdles before vaccinations can begin in the U.S.
The CDC’s Advisory Committee on Immunization Practices cast the vote in an emergency meeting Saturday after the Food and Drug Administration authorized the shot’s use. CDC Director Robert Redfield must give a final sign-off on the panel’s recommendations.